SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line
Source abstract
Abstract
Snail-1 known as one of the important transcription factor is a mediator of survival and cell migration, and expression is raised in numerous cancer types. Snail-1 gene may show a role in recurrence of several cancers including bladder cancer by down-regulating E-cadherin, inducing an epithelial to mesenchymal transition (EMT) and its related microRNAs (miRNAs). The aim of this study was to investigate the effect of a specific Snail-1 siRNA on apoptosis and alter EMT related miRNAs of EJ-138 (bladder cancer) cells. The cells were transfected with siRNAs using transfection reagent. The cytotoxic effects of Snail-1 siRNA, on bladder cancer cells were determined using MTT assay. Relative Snail-1 mRNA levels were measured by QRT- PCR, respectively. Apoptosis was measured by TUNEL test based on labeling of DNA strand breaks. We also evaluated miR-29b, miR-21, and miR-203 expression by QRT-PCR to determine alteration in miRNAs expression involved in EMT. Snail-1 siRNA significantly reduced mRNA expression levels in 48 h after transfection at the concentration of 60 pmol in bladder cancer cells. We also showed that the silencing of Snail-1 led to the induction of apoptosis. miR-21 and miR-29b depression have been shown in Snail-1 suppressed group in EJ-138 cells in vitro. These results propose that Snail-1 might play an important role in the progression of bladder cancer, and be a potential therapeutic target for trigger apoptosis and suppression of EMT-related miRNAs in bladder cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer Cells and Metastasis · Fibroblast Growth Factor Research · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;
International Branch (Aras), Tabriz University of Medical Sciences, Tabriz, Iran;
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;
Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran
References (26)
Show source-provided references
1. 10.1038/onc.2009.21410.1038/onc.2009.214 ↗
2. 10.1158/1535-7163.MCT-06-052110.1158/1535-7163.MCT-06-0521 ↗
3. 10.1016/S0025-7753(08)76435-210.1016/S0025-7753(08)76435-2 ↗
4. 10.1002/cncr.2094610.1002/cncr.20946 ↗
5. 10.3322/caac.2000610.3322/caac.20006 ↗
6. 10.1016/j.yexcr.2007.04.00110.1016/j.yexcr.2007.04.001 ↗
7. 10.1016/j.biopha.2015.08.03210.1016/j.biopha.2015.08.032 ↗
8. 10.1016/j.cellsig.2014.09.01810.1016/j.cellsig.2014.09.018 ↗
9. 10.1038/onc.2012.26010.1038/onc.2012.260 ↗
10. 10.1007/978-1-4614-5647-6_110.1007/978-1-4614-5647-6_1 ↗
11. 10.15171/apb.2016.02410.15171/apb.2016.024 ↗
12. Mansoori B · Cell Mol Biol (Noisy-le-Grand) · 2014 · 61 · 1
13. Mansoori B · Adv Pharm Bull · 2014 · 4 · 313
14. Montazami N · Cell Mol Biol (Noisy-le-Grand) · 2015 · 61 · 98
15. 10.1038/sj.onc.120999710.1038/sj.onc.1209997 ↗
16. 10.1158/0008-5472.CAN-07-231810.1158/0008-5472.CAN-07-2318 ↗
17. Sahranavard S · Res Pharm Sci · 2010 · 4 · 133
18. 10.1007/s12013-012-9451-110.1007/s12013-012-9451-1 ↗
19. 10.1016/j.cancergencyto.2007.05.00510.1016/j.cancergencyto.2007.05.005 ↗
20. Sugimachi K · . Clin Cancer Res · 2003 · 9 · 2657
21. 10.1093/jmcb/mjs04810.1093/jmcb/mjs048 ↗
22. 10.7150/ijms.382710.7150/ijms.3827 ↗
23. 10.1038/ncb190510.1038/ncb1905 ↗
24. 10.1200/JCO.2008.21.213410.1200/JCO.2008.21.2134 ↗
25. 10.1038/emboj.2011.31210.1038/emboj.2011.312 ↗
26. Zhang A · Anticancer Res · 2008 · 28 · 621